Table of Content

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Secondary sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.1.2.2 Breakdown of primaries 21
2.1.2.3 Key industry insights 22
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 PRECISION MEDICINE SOFTWARE: MARKET OVERVIEW 29
4.2 GEOGRAPHIC ANALYSIS: NORTH AMERICAN PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 30
4.3 US PRECISION MEDICINE SOFTWARE MARKET 31
4.4 GEOGRAPHICAL SNAPSHOT OF THE PRECISION MEDICINE SOFTWARE MARKET 32

5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Rising government funding in precision medicine initiatives 34
5.2.1.2 Partnerships among pharmaceutical and software companies 35
5.2.1.3 Entry of new players and VC funding 35
5.2.1.4 Growth in the number of cancer patients 35
5.2.2 RESTRAINTS 36
5.2.2.1 High cost of deployment 36
5.2.3 OPPORTUNITIES 36
5.2.3.1 Emerging countries 36
5.2.3.2 Cloud-based solutions 37
5.2.3.3 Artificial intelligence in precision medicine 37
5.2.4 CHALLENGES 37
5.2.4.1 Secure storage of large volumes of sequenced data 37
5.2.4.2 Lack of reimbursement for precision medicine-based treatments 38
5.2.4.3 Lack of skilled IT professionals in healthcare 38

6 PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 39
6.1 INTRODUCTION 40
6.2 ON-PREMISE DELIVERY MODE 40
6.2.1 BENEFITS OFFERED BY THE ON-PREMISE DELIVERY MODEL AND LIMITED PENETRATION OF CLOUD-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH 40
6.3 CLOUD-BASED DELIVERY MODE 42
6.3.1 OPEN-ACCESS NATURE OF CLOUD-BASED MODELS POSES SECURITY CHALLENGES 42

7 PRECISION MEDICINE SOFTWARE MARKET, BY END USER 44
7.1 INTRODUCTION 45
7.2 HEALTHCARE PROVIDERS 45
7.2.1 PRECISION MEDICINE IS USED BY HEALTHCARE PROVIDERS TO DETERMINE DISEASE SUSCEPTIBILITY AND PROVIDE PERSONALIZED TREATMENTS 45
7.3 RESEARCH CENTERS AND GOVERNMENT INSTITUTES 47
7.3.1 INCREASING FUNDING FOR RESEARCH WILL DRIVE THE USAGE AND ADOPTION OF PRECISION MEDICINE SOFTWARE IN THIS SEGMENT 47
7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 49
7.4.1 INCREASING EMPHASIS ON PHARMACOGENOMICS DUE TO ITS APPLICATIONS IN DRUG DEVELOPMENT IS TO DRIVE MARKET GROWTH 49
7.5 OTHER END USERS 51

8 PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 53
8.1 INTRODUCTION 54
8.2 ONCOLOGY 54
8.2.1 ONCOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE PRECISION MEDICINE SOFTWARE MARKET 54
8.3 PHARMACOGENOMICS 56
8.3.1 PHARMACOGENOMICS IS A POTENTIAL SOLUTION TO REDUCE HEALTHCARE COSTS ASSOCIATED WITH ADES AND POOR RESPONSE TO PHARMACOTHERAPY 56
8.4 RARE DISEASES 57
8.4.1 INCREASING INCIDENCE OF RARE DISEASES TO DRIVE MARKET GROWTH 57
8.5 OTHER APPLICATIONS 59

9 PRECISION MEDICINE SOFTWARE MARKET, BY REGION 61
9.1 INTRODUCTION 62
9.2 NORTH AMERICA 63
9.2.1 US 65
9.2.1.1 Government funding to support market growth in the US 65
9.2.2 CANADA 67
9.2.2.1 Rising incidence of cancer in Canada will drive the demand for precision medicine software 67
9.3 EUROPE 69
9.3.1 EU5 71
9.3.1.1 Favorable funding scenario will support market growth in EU5 71
9.3.2 REST OF EUROPE 73
9.4 ASIA 74
9.4.1 GROWING RESEARCH INVESTMENTS IN CHINA, JAPAN & INDIA WILL CONTRIBUTE TO MARKET GROWTH IN ASIA 74
9.5 REST OF THE WORLD 77

10 COMPETITIVE LANDSCAPE 80
10.1 OVERVIEW 80
10.2 MARKET RANKING OF PLAYERS, 2018 81
10.3 COMPETITIVE LEADERSHIP MAPPING 82
10.3.1 VISIONARY LEADERS 82
10.3.2 INNOVATORS 82
10.3.3 DYNAMIC DIFFERENTIATORS 82
10.3.4 EMERGING COMPANIES 82
10.4 COMPETITIVE SCENARIO 83
10.4.1 SOLUTION LAUNCHES 84
10.4.2 EXPANSIONS 84
10.4.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 85
10.4.4 ACQUISITIONS 86

11 COMPANY PROFILES 87
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 SYAPSE, INC. 87
11.2 2BPRECISE, LLC 89
11.3 FABRIC GENOMICS, INC. 91
11.4 FOUNDATION MEDICINE, INC. 92
11.5 SOPHIA GENETICS SA 94
11.6 PIERIANDX, INC. 96
11.7 N-OF-ONE, INC. (A SUBSIDIARY OF QIAGEN N.V.) 98
11.8 HUMAN LONGEVITY, INC. 100
11.9 TRANSLATIONAL SOFTWARE INC. 102
11.10 SUNQUEST INFORMATION SYSTEMS, INC. 104
11.11 GENE42, INC. 105
11.12 LIFEOMIC HEALTH, LLC 106

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 107
12.1 DISCUSSION GUIDE 107
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 111
12.3 AVAILABLE CUSTOMIZATIONS 113
12.4 RELATED REPORTS 113
12.5 AUTHOR DETAILS 114



List of Figures



FIGURE 1 RESEARCH METHODOLOGY: PRECISION MEDICINE SOFTWARE 17
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 23
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
FIGURE 7 PRECISION MEDICINE SOFTWARE MARKET SHARE, BY DELIVERY MODE, 2018 26
FIGURE 8 PRECISION MEDICINE SOFTWARE MARKET SHARE, BY END USER, 2018 27
FIGURE 9 PRECISION MEDICINE SOFTWARE MARKET SHARE, BY APPLICATION, 2018 27
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE PRECISION MEDICINE SOFTWARE MARKET 28
FIGURE 11 RISING GOVERNMENT FUNDING IN PRECISION MEDICINE INITIATIVES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 29
FIGURE 12 ON-PREMISE DELIVERY MODE ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PRECISION MEDICINE SOFTWARE MARKET IN 2018 30
FIGURE 13 HEALTHCARE PROVIDERS ACCOUNTED FOR THE LARGEST MARKET
SHARE IN 2018 31
FIGURE 14 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE
DURING THE FORECAST PERIOD 32
FIGURE 15 PRECISION MEDICINE SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 33
FIGURE 16 PRECISION MEDICINE SOFTWARE MARKET, BY REGION 2019 VS. 2024 (USD MILLION) 62
FIGURE 17 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET SNAPSHOT 63
FIGURE 18 EUROPE: PRECISION MEDICINE SOFTWARE MARKET SNAPSHOT 69
FIGURE 19 ASIA: PRECISION MEDICINE SOFTWARE MARKET SNAPSHOT 75
FIGURE 20 ROW: PRECISION MEDICINE SOFTWARE MARKET SNAPSHOT 78
FIGURE 21 KEY DEVELOPMENTS IN THE PRECISION MEDICINE SOFTWARE MARKET BETWEEN 2016 AND 2019 80
FIGURE 22 PRECISION MEDICINE SOFTWARE MARKET RANKING, BY KEY PLAYER (2018) 81
FIGURE 23 PRECISION MEDICINE SOFTWARE MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018 83

 

List of Tables



TABLE 1 GOVERNMENT INITIATIVES IN THE FIELD OF PRECISION MEDICINE SOFTWARE 34
TABLE 2 START-UP COMPANIES IN THE PRECISION MEDICINE SOFTWARE MARKET 35
TABLE 3 PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 40
TABLE 4 ON-PREMISE PRECISION MEDICINE SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 41
TABLE 5 NORTH AMERICA: ON-PREMISE PRECISION MEDICINE SOFTWARE MARKET BY COUNTRY, 2017–2024 (USD MILLION) 41
TABLE 6 EUROPE: ON-PREMISE PRECISION MEDICINE SOFTWARE MARKET BY REGION, 2017–2024 (USD MILLION) 41
TABLE 7 CLOUD-BASED PRECISION MEDICINE SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 43
TABLE 8 NORTH AMERICA: CLOUD-BASED PRECISION MEDICINE SOFTWARE MARKET BY COUNTRY, 2017–2024 (USD MILLION) 43
TABLE 9 EUROPE: CLOUD-BASED PRECISION MEDICINE SOFTWARE MARKET BY REGION, 2017–2024 (USD MILLION) 43
TABLE 10 PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 45
TABLE 11 PRECISION MEDICINE SOFTWARE MARKET FOR HEALTHCARE PROVIDERS BY REGION, 2017–2024 (USD MILLION) 46
TABLE 12 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 13 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 14 PRECISION MEDICINE SOFTWARE MARKET FOR RESEARCH CENTERS AND GOVERNMENT INSTITUTES, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 15 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR RESEARCH CENTERS AND GOVERNMENT INSTITUTES, BY COUNTRY 2017–2024 (USD MILLION) 48
TABLE 16 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR RESEARCH CENTERS AND GOVERNMENT INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 49
TABLE 17 PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 18 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2017–2024 (USD MILLION) 50
TABLE 19 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACEUTICAL
AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 50
TABLE 20 PRECISION MEDICINE SOFTWARE MARKET FOR OTHER END USERS BY REGION, 2017–2024 (USD MILLION) 51
TABLE 21 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET
FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 22 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR OTHER END USERS BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 23 PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 54
TABLE 24 PRECISION MEDICINE SOFTWARE MARKET FOR ONCOLOGY BY REGION, 2017–2024 (USD MILLION) 55
TABLE 25 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR ONCOLOGY BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 26 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR ONCOLOGY BY REGION, 2017–2024 (USD MILLION) 55
TABLE 27 PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACOGENOMICS BY REGION, 2017–2024 (USD MILLION) 56
TABLE 28 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 29 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR PHARMACOGENOMICS, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 30 PRECISION MEDICINE SOFTWARE MARKET FOR RARE DISEASES BY REGION, 2017–2024 (USD MILLION) 58
TABLE 31 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR RARE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 32 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR RARE DISEASES BY REGION, 2017–2024 (USD MILLION) 59
TABLE 33 PRECISION MEDICINE SOFTWARE MARKET FOR OTHER APPLICATIONS BY REGION, 2017–2024 (USD MILLION) 59
TABLE 34 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 35 EUROPE: PRECISION MEDICINE SOFTWARE MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 36 PRECISION MEDICINE SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 62
TABLE 37 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET BY COUNTRY, 2017–2024 (USD MILLION) 64
TABLE 38 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET BY DELIVERY MODE, 2017–2024 (USD MILLION) 64
TABLE 39 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET BY END USER, 2017–2024 (USD MILLION) 64
TABLE 40 NORTH AMERICA: PRECISION MEDICINE SOFTWARE MARKET BY APPLICATION, 2017–2024 (USD MILLION) 65
TABLE 41 US: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 66
TABLE 42 US: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 66
TABLE 43 US: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 67
TABLE 44 CANADA: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 67
TABLE 45 CANADA: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 68
TABLE 46 CANADA: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 68
TABLE 47 EUROPE: PRECISION MEDICINE SOFTWARE MARKET, BY REGION 2017–2024 (USD MILLION) 70
TABLE 48 EUROPE: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 70
TABLE 49 EUROPE: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 70
TABLE 50 EUROPE: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 71
TABLE 51 EU5: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 72
TABLE 52 EU5: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 72
TABLE 53 EU5: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 72
TABLE 54 ROE: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 73
TABLE 55 ROE: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 73
TABLE 56 ROE: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 74
TABLE 57 ASIA: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 76
TABLE 58 ASIA: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 76
TABLE 59 ASIA: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 76
TABLE 60 ROW: PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE 2017–2024 (USD MILLION) 78
TABLE 61 ROW: PRECISION MEDICINE SOFTWARE MARKET, BY END USER 2017–2024 (USD MILLION) 79
TABLE 62 ROW: PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION 2017–2024 (USD MILLION) 79
TABLE 63 SOLUTION LAUNCHES 84
TABLE 64 EXPANSIONS 84
TABLE 65 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 85
TABLE 66 ACQUISITIONS 86